Article Details

MacroGenics Announces FDA Approval of MARGENZA™ for Patients with Pretreated Metastatic ...

Retrieved on: 2020-12-16 21:33:45

Tags for this article:

Click the tags to see associated articles and topics

MacroGenics Announces FDA Approval of MARGENZA™ for Patients with Pretreated Metastatic .... View article details on hiswai:

Excerpt

(Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative <b>monoclonal antibody</b>-based therapeutics for ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo